Ascentage Pharma Group International (AAPG) Cash & Current Investments (2022 - 2024)
Historic Cash & Current Investments for Ascentage Pharma Group International (AAPG) over the last 3 years, with Q4 2024 value amounting to $124.3 million.
- Ascentage Pharma Group International's Cash & Current Investments fell 1376.01% to $124.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $124.3 million, marking a year-over-year decrease of 1376.01%. This contributed to the annual value of $124.3 million for FY2024, which is 1257.17% down from last year.
- As of Q4 2024, Ascentage Pharma Group International's Cash & Current Investments stood at $124.3 million, which was down 1376.01% from $144.2 million recorded in Q4 2023.
- Ascentage Pharma Group International's 5-year Cash & Current Investments high stood at $189.2 million for Q4 2022, and its period low was $124.3 million during Q4 2024.
- Moreover, its 3-year median value for Cash & Current Investments was $144.2 million (2023), whereas its average is $152.6 million.
- Per our database at Business Quant, Ascentage Pharma Group International's Cash & Current Investments tumbled by 2380.02% in 2023 and then tumbled by 1376.01% in 2024.
- Ascentage Pharma Group International's Cash & Current Investments (Quarter) stood at $189.2 million in 2022, then fell by 23.8% to $144.2 million in 2023, then fell by 13.76% to $124.3 million in 2024.
- Its last three reported values are $124.3 million in Q4 2024, $144.2 million for Q4 2023, and $189.2 million during Q4 2022.